A Mark Richards Selected Research

AM5

5/2012

Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Mark Richards Research Topics

Disease

159	Heart Failure 04/2024 - 01/2002
58	Myocardial Infarction 05/2024 - 04/2002
26	Acute Coronary Syndrome 04/2024 - 06/2003
26	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 05/2002
19	Coronary Disease (Coronary Heart Disease) 04/2024 - 04/2006
16	Hypertension (High Blood Pressure) 01/2023 - 04/2002
14	Fibrosis (Cirrhosis) 04/2024 - 02/2007
13	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 01/2005
13	Chest Pain (Chest Pains) 01/2022 - 03/2011
13	Heart Diseases (Heart Disease) 01/2019 - 03/2004
11	Dyspnea (Shortness of Breath) 04/2024 - 08/2003
9	Infarction (Infarctions) 06/2020 - 04/2002
8	Inflammation (Inflammations) 04/2024 - 01/2013
6	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 04/2003
6	Hypertrophy 01/2020 - 02/2007
6	ST Elevation Myocardial Infarction 01/2018 - 10/2008
5	Ischemia 01/2024 - 09/2009
5	Stroke (Strokes) 01/2023 - 01/2019
5	Atrial Fibrillation 01/2023 - 08/2006
5	Atherosclerosis 01/2023 - 01/2019
5	Diabetes Mellitus 01/2019 - 02/2008
5	Left Ventricular Dysfunction 05/2013 - 05/2002
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2023 - 02/2007
4	Obesity 01/2023 - 01/2019
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2015
4	Body Weight (Weight, Body) 07/2019 - 05/2012
4	Reperfusion Injury 01/2016 - 10/2006
4	Systolic Heart Failure 01/2012 - 02/2004
3	Hemorrhage 02/2024 - 07/2013
3	Atherosclerotic Plaque (Atheroma) 01/2023 - 11/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2013
3	Thrombosis (Thrombus) 11/2021 - 05/2012
3	Hypoxia (Hypoxemia) 01/2016 - 10/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012 - 10/2009
2	Convalescence 04/2024 - 11/2019
2	Rupture 01/2023 - 11/2020
2	Ventricular Remodeling 12/2022 - 04/2002
2	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2011

Drug/Important Bio-Agent (IBA)

51	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 05/2002
48	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2009
46	Natriuretic PeptidesIBA 10/2023 - 01/2002
35	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 01/2005
26	TroponinIBA 05/2024 - 05/2002
21	Peptides (Polypeptides)IBA 04/2024 - 05/2002
21	UrocortinsIBA 11/2017 - 10/2002
16	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2006
14	Troponin T (Troponin T1)IBA 01/2022 - 08/2006
11	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 04/2003
10	AdrenomedullinIBA 01/2020 - 01/2002
9	Hormones (Hormone)IBA 09/2009 - 05/2002
8	Neprilysin (Neutral Endopeptidase)IBA 01/2024 - 08/2015
8	AldosteroneIBA 04/2015 - 01/2002
7	CreatinineIBA 04/2024 - 04/2003
7	CollagenIBA 04/2024 - 01/2013
7	LipidsIBA 01/2023 - 01/2011
7	Troponin IIBA 01/2022 - 06/2012
6	trans-crotonin (CTN)IBA 05/2024 - 05/2016
6	Mineralocorticoid Receptor AntagonistsIBA 04/2024 - 08/2008
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 06/2002
6	omega-Chloroacetophenone (Mace)IBA 01/2023 - 06/2012
6	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2021 - 06/2010
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 06/2002
6	Neurotransmitter Agents (Neurotransmitter)IBA 08/2011 - 04/2002
5	CholesterolIBA 10/2021 - 06/2003
5	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2013
5	SodiumIBA 10/2012 - 11/2002
4	Blood Proteins (Serum Proteins)IBA 02/2024 - 06/2006
4	Messenger RNA (mRNA)IBA 01/2024 - 12/2009
4	Angiotensin Receptor AntagonistsIBA 01/2023 - 01/2018
4	Adenosine Diphosphate (ADP)IBA 01/2016 - 03/2011
4	Protein Sorting Signals (Signal Peptide)IBA 12/2015 - 07/2010
4	Vasodilator Agents (Vasodilators)IBA 09/2015 - 01/2002
4	Betaine (C.B.B.)FDA Link 01/2014 - 10/2009
4	Endothelins (Endothelin)IBA 05/2012 - 06/2004
4	ReninIBA 11/2009 - 04/2003
3	Growth Differentiation Factor 15IBA 04/2024 - 08/2016
3	DiureticsIBA 01/2023 - 01/2007
3	oxidized low density lipoproteinIBA 12/2022 - 03/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 01/2018
3	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 12/2014 - 12/2008
3	MyoglobinIBA 04/2012 - 07/2010
3	MB Form Creatine KinaseIBA 04/2012 - 07/2010
3	urotensin IIIBA 11/2009 - 08/2002
3	Peroxidase (Myeloperoxidase)IBA 06/2009 - 06/2006
2	Urokinase Plasminogen Activator ReceptorsIBA 04/2024 - 07/2019
2	Dihydrotachysterol (AT 10)IBA 04/2024 - 10/2008
2	TicagrelorIBA 02/2024 - 11/2021
2	IntegrinsIBA 12/2023 - 01/2023
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2023 - 01/2021
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2023 - 01/2023
2	Apolipoproteins E (ApoE)IBA 01/2023 - 03/2012
2	SaltsIBA 01/2023 - 02/2008
2	Vitamin D FDA LinkGeneric 08/2022 - 01/2022
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2022

Therapy/Procedure

36	Therapeutics 01/2022 - 05/2002
5	Length of Stay 10/2019 - 06/2005
4	Patient Readmission 11/2021 - 04/2011
4	Ligation 06/2020 - 11/2008
4	Percutaneous Coronary Intervention 10/2018 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2018 - 05/2002